tiprankstipranks
Trending News
More News >

ImmuPharma Schedules AGM, Shares Annual Report

ImmuPharma Schedules AGM, Shares Annual Report

ImmuPharma (GB:IMM) has released an update.

Confident Investing Starts Here:

ImmuPharma PLC, a biopharmaceutical company focusing on peptide-based therapeutics, has announced its Annual General Meeting (AGM) to be held on June 28, 2024. Shareholders are informed that the AGM details and Annual Report for 2023 are available on the company’s website. The company specializes in developing treatments for autoimmune diseases, with its leading program, P140, showing promise for Lupus and other autoimmune disorders.

For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1